企業プロフィール
Merus 株価・ニュース・カタリスト
- ティッカー:
- MRUS
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Netherlands
株価変動の要因
Current closing-price context is not available for MRUS.
企業概要
事業概要
Merus is a clinical-stage antibody company focused on precision oncology and bispecific antibody development. Its platform is built around engineered immunology and cancer programs.
所在地とセクター分類
Headquartered in the Netherlands and listed on NASDAQ as an ADR, Merus has a global biotechnology footprint.
ビジネスモデルの特徴
The business depends on clinical data, platform validation, and the ability to create differentiated oncology assets.
バイオ業界での位置付け
Merus is a platform antibody name with meaningful upside if its bispecific science keeps validating clinically.
今後のカタリスト
- Merus's catalysts are petosemtamab and zenocutuzumab, with the next data updates deciding whether the bispecific oncology story keeps strengthening. The company still needs the next readout to make the platform feel more than promising.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。